Shares of Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) reached a new 52-week low on Thursday . The company traded as low as $6.13 and last traded at $6.41, with a volume of 996306 shares changing hands. The stock had previously closed at $6.35.
Analyst Upgrades and Downgrades
A number of equities research analysts recently issued reports on the stock. Craig Hallum decreased their price target on shares of Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating on the stock in a research note on Friday, February 14th. Roth Mkm lowered their price target on shares of Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating for the company in a report on Friday, February 14th. Barclays dropped their price target on Aspen Aerogels from $25.00 to $13.00 and set an "overweight" rating for the company in a research report on Wednesday, February 19th. Seaport Res Ptn downgraded Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, February 12th. Finally, B. Riley dropped their target price on Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating for the company in a report on Wednesday, February 19th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $19.11.
Check Out Our Latest Stock Analysis on Aspen Aerogels
Aspen Aerogels Stock Down 2.7 %
The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The company has a 50-day simple moving average of $8.36 and a 200 day simple moving average of $13.83. The company has a market cap of $437.21 million, a P/E ratio of 33.28 and a beta of 2.35.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, topping analysts' consensus estimates of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. On average, equities analysts anticipate that Aspen Aerogels, Inc. will post 0.17 EPS for the current year.
Institutional Trading of Aspen Aerogels
A number of large investors have recently modified their holdings of the company. Lord Abbett & CO. LLC bought a new stake in Aspen Aerogels during the 3rd quarter valued at $10,126,000. Sanders Morris Harris LLC increased its stake in shares of Aspen Aerogels by 337.5% during the fourth quarter. Sanders Morris Harris LLC now owns 35,000 shares of the construction company's stock valued at $436,000 after buying an additional 27,000 shares during the period. Geode Capital Management LLC raised its holdings in shares of Aspen Aerogels by 5.7% in the third quarter. Geode Capital Management LLC now owns 1,385,968 shares of the construction company's stock valued at $38,385,000 after acquiring an additional 75,024 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in Aspen Aerogels by 153.2% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 399,534 shares of the construction company's stock worth $11,063,000 after acquiring an additional 241,741 shares during the period. Finally, Barclays PLC grew its holdings in Aspen Aerogels by 333.8% during the 3rd quarter. Barclays PLC now owns 92,302 shares of the construction company's stock worth $2,557,000 after acquiring an additional 71,024 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.
Aspen Aerogels Company Profile
(
Get Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Featured Articles
Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
